BUFFALO, N.Y. (WIVB) — A cancer vaccine being tested by Roswell Park's cancer center is showing longer survival rates for some patients with glioblastoma, according to test results released Wednesday. The vaccine, called SurVaxM and developed by MimiVax Inc. and Roswell Park, was administered to 2 33 glioblastoma patients across 11 cancer centers across the country. [...] ...read more read less